Global Intranasal Vaccine is projected to reach US$948 million by 2033

Global Intranasal Vaccine Market was valued at USD 568 million in 2024 and is projected to reach USD 948 million by 2033, growing at a CAGR of 5.4% during the forecast period. Intranasal vaccines, administered via the nasal route, offer a needle-free...